Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Non-Current Assets: 2020-2022

Historic Non-Current Assets for Candel Therapeutics (CADL) over the last 3 years, with Dec 2022 value amounting to $5.7 million.

  • Candel Therapeutics' Non-Current Assets fell 16.46% to $5.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $5.0 million, marking a year-over-year decrease of 16.46%. This contributed to the annual value of $5.7 million for FY2022, which is 34.88% up from last year.
  • As of FY2022, Candel Therapeutics' Non-Current Assets stood at $5.7 million, which was up 34.88% from $4.3 million recorded in FY2021.
  • In the past 5 years, Candel Therapeutics' Non-Current Assets ranged from a high of $5.7 million in FY2022 and a low of $3.1 million during FY2020.
  • Moreover, its 3-year median value for Non-Current Assets was $4.3 million (2021), whereas its average is $4.4 million.
  • Data for Candel Therapeutics' Non-Current Assets shows a peak YoY skyrocketed of 35.84% (in 2021) over the last 5 years.
  • Candel Therapeutics' Non-Current Assets (Yearly) stood at $3.1 million in 2020, then surged by 35.84% to $4.3 million in 2021, then spiked by 34.88% to $5.7 million in 2022.